Delivery Order SPE2DB24D2100-SPE2DB25FBFHP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,442.40 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray in 16-gram units. This firm fixed-price delivery order, issued on July 24, 2025, represents a competitive award with no set-aside designation and is scheduled for ultimate completion by July 25, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in a 16-gram formulation. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,030.32 and is scheduled for completion by August 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. This firm fixed price contract, valued at $1,465.32, represents a non-competitive delivery order with an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves as a child order under a larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,606.19 on August 15, 2025, for Fluticasone Propionate 50 microgram nasal spray in 16-gram units. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed by August 18, 2025, with the product to be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,694.16 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray (16 grams). The contract employs firm fixed price terms with an ultimate completion date of July 28, 2025, and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its Corporate Office location. This delivery order represents a competitive award...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.20 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray in 16-gram units. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to support federal medical procurement needs, with performance centered at AmerisourceBergen's corporate offices in...
- The Defense Logistics Agency awarded a delivery order valued at $2,008.40 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray (16 grams) on July 30, 2025, with completion targeted for July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child...
- The Defense Logistics Agency awarded a $2,369.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray (16 grams), with an ultimate completion date of August 11, 2025. This non-set-aside contract was competitively awarded on August 8, 2025, with performance to be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,214.68 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. This non-competitive, firm fixed-price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. This firm fixed-price delivery order, valued at $2,347.96, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open competition...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFHPDelivery Order
The Defense Logistics Agency awarded a $1,232.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray (16 grams) on July 18, 2025, with an ultimate completion date of July 21, 2025. This contract was not designated under any set-aside program and represents a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a broad spectrum of medications and medical supplies to support military healthcare systems and federal medical procurement needs. The company's contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements through open competition, with this specific delivery order reflecting routine medical supply fulfillment to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/18/25 |